Detrusor Overactivity Completed Phase 2 Trials for Vardenafil (DB00862)

IndicationStatusPhase
DBCOND0035562 (Detrusor Overactivity)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00478881A Study To Assess If 10 mg Vardenafil (BAY38-9456) Taken Twice Daily For 6 Weeks Has An Effect On Bladder FunctionTreatment